Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers.

Cells · 2023 · PMC9954556 · PMID 36831248

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Semiquantitative analysis of expression indicated highly significant differences in the tumors compared with normal brain and no significant difference in staining between GBM and low-grade astrocytomas.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.